TRVI (TRVI) Stock Price & Analysis
TRVI (TRVI) rose 0.00% to USD 17.54 as of July 25, 2026 at 04:13 UTC, according to Nexqual real-time market data.
TRVI last closed at USD 17.54; the session ranged USD 16.92–17.54 on volume of 1,425,723 shares. Market capitalization is —, with a 52-week range of USD 6.55–20.22 (NGM). Source: Nexqual, July 25, 2026 at 04:13 UTC.
Key Statistics (as of July 25, 2026 at 04:13 UTC)
| Price | USD 17.54 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 17.54 |
| Open | USD 17.54 |
| Day Range | USD 16.92 – 17.54 |
| 52-Week Range | USD 6.55 – 20.22 |
| Volume | 1,425,723 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (TRVI)
Nexqual's technical model rates TRVI "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 04:13 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 53.66 (neutral) |
| vs SMA50 | Above (USD 16.01) |
| MACD | 0.36 (positive) |
From TRVI's Latest SEC 10-K Filing (filed 2026-03-17)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FULC | Fulcrum Therapeutics, Inc. | USD 3.72 | ▲ 0.54% |
| XFOR | X4 Pharmaceuticals, Inc. | USD 3.85 | ▲ 4.19% |
| VRCA | Verrica Pharmaceuticals Inc. | USD 5.02 | ▼ 11.93% |
| TARA | Protara Therapeutics, Inc. | USD 4.02 | ▼ 1.47% |
| STOK | Stoke Therapeutics, Inc. | USD 29.3 | ▲ 1.17% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:13 UTC. This page is informational and not investment advice.